Navigation Links
Breast Cancer Survivors Growing in Numbers

Approximately two million breast cancer survivors have been found to be alive in America today. Screening and treatment advances have helped in the longer management of the disease. //

However it has been estimated that about a third of these long-term survivors do suffer from debilitating fatigue making normal activities of life difficult to manage.

Researchers at the University of California at Los Angeles found that not all survivors suffer from fatigue. It was found that the blood of fatigued survivors contained an abnormally high level of proteins indicating that their immune inflammatory response was still working at full-tilt. Non-fatigued survivors did not have high levels of this protein.

According to Dr. Michael Irwin of UCLA’s Jonsson Cancer Center and lead author of the research ‘It appears there is an activation of the immune system that’s present and that probably occurs in the midst of treatment but in the women that have persistent fatigue, that immune activation, we hypothesize, that those women don’t turn off their immune system.’

The results of the study have been published in the May 1st issue of Clinical Cancer Research. Their study revealed that persistent fatigue was unrelated to the type of treatment received for the breast cancer nor was it related to the stage of her disease at diagnosis.

Instead the hypothesis of the researchers seemed to indicate that the brain and immune system get stuck in an endless feedback loop and immune proteins communicated with brain to keep the production of immune proteins turned on.

Dr. Irwin opined that the abnormally high level of anti-inflammatory proteins could easily be a “marker” to identify women at greater risk of developing persistent fatigue and thereby a need for additional support.

The researchers plan to investigate whether that endless feedback loop could be broken through mind-body disciplines and exercise tha
'"/>




Page: 1 2

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
(Date:12/5/2008)...fer heart problems, study says , , FRIDA...ly lung disease idiopathic pulmonary fibrosis (IPF...the disease to suffer severe cardiac events such a..., "If you look at them over time, people with IP... coronary syndrome, which is a greater increase th...
(Date:12/5/2008)...For many, city living is at its,finest during the...rther,glamorized by the festive parties, larger t...the joyful atmosphere. However, for many single ci...an emotionally trying time,filled with expectatio...,romance during the holidays have developed a neg...
(Date:12/5/2008)...- Norgine, the leading European specialty pharmace...anted Medical Futures the exclusive rights to mark... patent-protected product developed by Norgine for...tuations where a clean bowel is required. The prod...A by its partner Salix Pharmaceuticals. , In re...
(Date:12/5/2008).../ - QLT Inc. (NASDAQ: QLTI ; TSX: QLT) announced... bid circular (the "Circular") to its shareholders...n" tender offer for up to US$50 million of common ...The Circular is being filed with the securities re...da. Under the terms of the tender offer, sharehold...
Breaking Medicine News(10 mins):Health News:Lung Disease Tied to Increased Risk for Cardiac Events 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 3Health News:Medical Futures partners with Norgine for MOVIPREP(R) in Canada 2Health News:QLT announces commencement of tender offer 2Health News:QLT announces commencement of tender offer 3Health News:QLT announces commencement of tender offer 4Health News:QLT announces commencement of tender offer 5
...men at high risk of getting breast cancer in UK ar... Imaging) scans between the ages of 20-49//. Studi...,000 women yearly in the UK can be detected by the...e breast cancer cases are hereditary. Women with a...
...New Zealand scientist warned Wednesday of sophisti...ke medicines that kill thousands of people every y...it pills not only lacked the proper ingredients to...ontained carcinogens, solvents and even remains of...
...pe has been found to be a common crime with studie...n has committed rape at least once//. These shock...earch unit of the country's Medical Research Counc...of ages of 15 to 26 years revealed about 8 per cen...
...okers will be denied life-changing operations unle...oday. Many cash-strapped hospitals say that they w...ts// until they are going to give up on smoking. T...so be denied treatment. Smokers are at a big ris...
Other Medicine News:Health News:New Zealand Scientist Warns On Fake Drugs 2Health News:Smokers Warned to Give up else Face Denial of Operations 2Health News:Smokers Warned to Give up else Face Denial of Operations 3
(Date:12/3/2008).... Jude treatment alleviates long-term anemia and o...plications , , MEMPHIS, Tenn., Dec. 3 /PRN...nsert a corrective gene into mouse blood cells, sc...have alleviated sickle cell disease pathology. In ...ted mice showed essentially no difference from nor...
(Date:12/3/2008)..., Del., Dec. 3 Isogen, a contract ...erile filling, announced it has retained a,strate... to meet the global,biopharma demand for Isogen,s...d a successful first round series of capital,inve...acility in Q1 2009 to,deliver on the previously u...
(Date:12/3/2008)...EGO, Dec. 3 Vical Incorp...sive, binding letter of intent with EIP,Eczacibas...g of the company,s,Allovectin-7(R) immunotherapeu...epublic of Northern Cyprus. EIP has agreed to obta...ritory and to pay Vical upfront and milestone paym...
(Date:12/2/2008)...DGE, Mass., Dec. 2 Biopu...that the U.S. Naval Medical Research Center,(NMRC...n (FDA) a revised,investigational new drug (IND) ...mpany,s oxygen therapeutic Hemopure(R) [hemoglobin...ttlefield treatment of trauma patients. The study ...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Sage Software Healthcare Inc Announces Intergy by Sage and Intergy EHR by Sage installations for 2007 7649 1Sage Software Healthcare Inc Announces Intergy by Sage and Intergy EHR by Sage installations for 2007 7649 2Infant Development Program from EASY Baby Takes On the Sixty Percent Increase in Developmental Delays in Children 7647 1Infant Development Program from EASY Baby Takes On the Sixty Percent Increase in Developmental Delays in Children 7647 2Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 1Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 2Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 3Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 1Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 2Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 3
...PARK, Calif.--(BUSINESS WIRE)--Jun 11, 2007 - Gero...esentation of,research studies indicating that GRN...C)-based therapeutic for the treatment of,spinal c...mune,system., Presented by Geron scientist Ross Ok...ieties meeting in San Diego, the findings,could me...
...he Netherlands, June 11, 2007-Sugammadex - the nov...eveloped by Organon,the human healthcare business...pivotal trial a 9-12 times faster reversal of,neur...hout evidence,of post operative residual curarizat..., 2 The results of this pivotal Aurora trial,were ...
Other Medicine Technology:Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 3
...ne-125 implant is a combination of innovative desi...e visibility that makes BrachySource I-125 implant...You can be confident that every BrachySource I-125...rvices which is required by clinicians who must me...
...ne-125 implant is a combination of innovative desi...e visibility that makes BrachySource I-125 implant...You can be confident that every BrachySource I-125...rvices which is required by clinicians who must me...
The Double-J Closed Tip Ureteral Stent design revolutionized stenting over 15 years ago. Today, it remains one of the most widely used stents in the world. An exclusive ACMI design allows one-step in
...ternal drainage from the ureteropelvic junction to...e segment with no sideports prevents postoperative...ingrowth of the ureteral wall to the stent. Suppli...-time use. CAUTION: Periodic evaluation is advised...
Medicine Products: